Cytarabine Dose for Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Lowenberg, Bob [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 22期
关键词：
CHEMOTHERAPY; THERAPY; INDUCTION; ADULTS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2168 / 2169
页数：2
相关论文
共 50 条
  • [31] Modulation of cytarabine resistance in childhood acute myeloid leukemia
    Hubeek, I
    Peters, GJ
    Broekhuizen, AJF
    Zwaan, CM
    Creutzig, U
    Kaspers, GJL
    LEUKEMIA, 2003, 17 (03) : 681 - 681
  • [32] TREATMENT OF ACUTE MYELOID LEUKEMIA IN ADULTS WITH CYTARABINE AND THIOGUANINE
    FULLE, HH
    PRIBILLA, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (18) : 711 - +
  • [33] Toward Personalization of Cytarabine Dosing in Acute Myeloid Leukemia
    Jordheim, Lars Petter
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (07) : 784 - 786
  • [34] Arsenic Trioxide and Low-dose Cytarabine in Older Patients With Untreated Acute Myeloid Leukemia, Excluding Acute Promyelocytic Leukemia
    Roboz, Gail J.
    Ritchie, Ellen K.
    Curcio, Tania
    Provenzano, Juliette
    Carlin, Rebecca
    Samuel, Michael
    Wittenberg, Beth
    Mazumdar, Madhu
    Christos, Paul J.
    Mathew, Susan
    Allen-Bard, Sandra
    Feldman, Eric J.
    CANCER, 2008, 113 (09) : 2504 - 2511
  • [35] Outcomes Associated with Antimicrobial Use during High Dose Cytarabine Consolidation in Acute Myeloid Leukemia
    Vale, Colin
    Farmakiotis, Dimitrios
    Egan, Pamela C.
    Ingham, Randall
    Reagan, John L.
    BLOOD, 2018, 132
  • [36] VERY-LOW-DOSE CYTARABINE FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA IN THE ELDERLY
    WORSLEY, A
    MUFTI, GJ
    COPPLESTONE, JA
    OSCIER, DG
    HAMBLIN, TJ
    LANCET, 1986, 1 (8487): : 966 - 966
  • [37] Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
    Roellig, C.
    Kramer, M.
    Gabrecht, M.
    Haenel, M.
    Herbst, R.
    Kaiser, U.
    Schmitz, N.
    Kullmer, J.
    Fetscher, S.
    Link, H.
    Mantoyani-Loeffler, L.
    Kruempelmann, U.
    Neuhaus, T.
    Heits, F.
    Einsele, H.
    Ritter, B.
    Bornhaeuser, M.
    Schetelig, J.
    Thiede, C.
    Mohr, B.
    Schaich, M.
    Platzbecker, U.
    Schaefer-Eckart, K.
    Kraemer, A.
    Berdel, W. E.
    Serve, H.
    Ehninger, G.
    Schuler, U. S.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 973 - 978
  • [38] Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
    Zhang, Wenjun
    Ding, Yi
    Wu, Hao
    Chen, Yuhua
    Lu, Huina
    Chen, Chunying
    Fu, Jianfei
    Wang, Weiguang
    Liang, Aibin
    Zou, Shanhua
    MEDICINE, 2014, 93 (27)
  • [39] High-dose mercaptopurine and intermediate-dose cytarabine during first remission of acute myeloid leukemia
    Canpolat, C
    Jeha, S
    Lockhart, S
    Ramirez, I
    Zipf, T
    Pinkel, D
    CANCER INVESTIGATION, 1997, 15 (02) : 121 - 126
  • [40] Problems related to resistance to cytarabine in acute myeloid leukemia
    Cros, E
    Jordheim, L
    Dumontet, C
    Galmarini, CM
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1123 - 1132
12345